AVGR - Avangardco Investments Public Ltd Stock Price, Fair Value and News

$0.780.00 (0.00%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

AVGR Price Action

Last 7 days

-4.8%

Last 30 days

-12.2%

Last 90 days

-31.3%

Trailing 12 Months

-77.0%

AVGR RSI Chart

AVGR Valuation

Market Cap

2.5M

Price/Earnings (Trailing)

-0.13

Price/Sales (Trailing)

0.34

EV/EBITDA

0.06

Price/Free Cashflow

-0.18

AVGR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

AVGR Fundamentals

AVGR Revenue

Revenue (TTM)

7.3M

Rev. Growth (Yr)

-9.19%

Rev. Growth (Qtr)

-10.67%

AVGR Earnings

Earnings (TTM)

-18.6M

Earnings Growth (Yr)

17.2%

Earnings Growth (Qtr)

15.04%

AVGR Profitability

Operating Margin

20.94%

EBT Margin

-772.91%

Return on Equity

-480.23%

Return on Assets

-136.82%

Free Cashflow Yield

-562.29%

AVGR Investor Care

Shares Dilution (1Y)

133.32%

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	7.6M	7.4M	7.3M	0
2023	8.3M	8.2M	7.7M	7.7M
2022	9.5M	8.8M	8.7M	8.3M
2021	9.1M	10.4M	10.5M	10.1M
2020	9.6M	8.7M	8.6M	8.8M
2019	7.9M	8.2M	8.6M	9.1M
2018	8.3M	7.9M	7.8M	7.9M
2017	18.2M	15.9M	12.7M	9.9M
2016	13.2M	14.8M	17.4M	19.2M
2015	11.2M	10.8M	10.9M	10.7M
2014	12.5M	12.1M	11.7M	11.2M
2013	0	0	0	13.0M

Get all data in R, Python etc through our Historical Stock Data APIs

About Avangardco Investments Public Ltd

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.

CEO	Mr. Jeffrey M. Soinski
WEBSITE	https://avinger.com
SECTOR	Healthcare
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	71

Avangardco Investments Public Ltd Frequently Asked Questions

What is the ticker symbol for Avangardco Investments Public Ltd? What does AVGR stand for in stocks?

AVGR is the stock ticker symbol of Avangardco Investments Public Ltd. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Avangardco Investments Public Ltd (AVGR)?

As of Tue Nov 19 2024, market cap of Avangardco Investments Public Ltd is 2.49 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AVGR stock?

You can check AVGR's fair value in chart for subscribers.

Is Avangardco Investments Public Ltd a good stock to buy?

The fair value guage provides a quick view whether AVGR is over valued or under valued. Whether Avangardco Investments Public Ltd is cheap or expensive depends on the assumptions which impact Avangardco Investments Public Ltd's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AVGR.

What is Avangardco Investments Public Ltd's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Nov 19 2024, AVGR's PE ratio (Price to Earnings) is -0.13 and Price to Sales (PS) ratio is 0.34. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AVGR PE ratio will change depending on the future growth rate expectations of investors.